ARYL AMIDINES - A NEW CLASS OF POTENT ORALLY-ACTIVE LEUKOTRIENE-B4 ANTAGONIST

被引:0
|
作者
MAIN, AJ [1 ]
BARSKY, LI [1 ]
MORRISSEY, M [1 ]
CADILLA, R [1 ]
BOEHM, C [1 ]
ZHANG, YC [1 ]
SUH, HS [1 ]
BOXER, JB [1 ]
POWERS, DB [1 ]
FUJIMOTO, RA [1 ]
DOTI, RA [1 ]
HEALY, CT [1 ]
SELIGMANN, BE [1 ]
UZIELFUSI, S [1 ]
JARVIS, MF [1 ]
SILLS, MA [1 ]
JACKSON, RH [1 ]
LIPSON, KE [1 ]
CHIN, MH [1 ]
PELLAS, TC [1 ]
PASTOR, G [1 ]
FRYER, LR [1 ]
RAYCHAUDHURI, AA [1 ]
KOTYUK, BL [1 ]
机构
[1] CIBA GEIGY CORP,DIV PHARMACEUT,RES DEPT,SUMMIT,NJ 07901
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1994年 / 207卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:3 / MEDI
相关论文
共 50 条
  • [31] POTENT, ORALLY-ACTIVE CARBOXYLATE REPLACEMENT ANALOGS OF THE ENDOTHELIN RECEPTOR ANTAGONIST L-749,329
    FITCH, KJ
    WALSH, TF
    TOUPENCE, RB
    WILLIAMS, DL
    NOLAN, NA
    OBRIEN, JA
    PETTIBONE, DJ
    KIVLIGHN, SD
    KRAUSE, SM
    CLAYTON, FC
    ZINGARO, GJ
    SIEGL, PKS
    GREENLEE, WJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 162 - MEDI
  • [32] RS-39604 - A POTENT, SELECTIVE, ORALLY-ACTIVE AND LONG-LASTING 5-HT4 RECEPTOR ANTAGONIST
    HEGDE, SS
    BONHAUS, DW
    LEUNG, E
    WONG, EHF
    JOHNSON, LG
    CLARK, RD
    FLIPPIN, LA
    EGLEN, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P380 - P380
  • [33] DESIGN, SYNTHESIS AND EVALUATION OF THE POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST L-734,217
    DUGGAN, ME
    NAYLOROLSEN, AM
    PERKINS, JJ
    ANDERSON, PS
    CHANG, CTC
    COOK, JJ
    GOULD, RJ
    IHLE, NC
    HARTMAN, GD
    LYNCH, JJ
    LYNCH, RJ
    MANNO, PD
    SCHAFFER, LW
    SMITH, RL
    BEDNAR, B
    BEDNAR, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 2 - MEDI
  • [34] VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES
    BUHLMAYER, P
    FURET, P
    CRISCIONE, L
    DEGASPARO, M
    WHITEBREAD, S
    SCHMIDLIN, T
    LATTMANN, R
    WOOD, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) : 29 - 34
  • [35] PROTECTIVE ACTIONS OF A LEUKOTRIENE-B4 ANTAGONIST IN SPLANCHNIC ISCHEMIA AND REPERFUSION IN RATS
    KARASAWA, A
    GUO, JP
    MA, XL
    TSAO, PS
    LEFER, AM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02): : G191 - G198
  • [36] SYNTHESIS OF 4''-DEOXY MOTILIDES - IDENTIFICATION OF A POTENT AND ORALLY-ACTIVE PROKINETIC DRUG CANDIDATE
    LARTEY, PA
    NELLANS, HN
    FAGHIH, R
    PETERSEN, A
    EDWARDS, CM
    FREIBERG, L
    QUIGLEY, S
    MARSH, K
    KLEIN, LL
    PLATTNER, JJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) : 1793 - 1798
  • [37] MULTIPLE ACTIONS OF THE LEUKOTRIENE-B4 RECEPTOR ANTAGONIST SC-41930
    VILLANIPRICE, D
    YANG, DC
    WALSH, RE
    FRETLAND, DJ
    KEITH, RH
    KOCAN, G
    KACHUR, JF
    GAGINELLA, TS
    TSAI, BS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 260 (01): : 187 - 191
  • [38] BIOLOGICAL CHARACTERISTICS OF THE NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST - S-1762
    JUST, M
    HROPOT, M
    JABLONKA, B
    KONIG, W
    STILZ, HU
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1444 - 1444
  • [39] A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST
    CHAKRAVARTY, PK
    NAYLOR, EM
    CHEN, A
    CHANG, RSL
    CHEN, TB
    FAUST, KA
    LOTTI, VJ
    KIVLIGHN, SD
    GABLE, RA
    ZINGARO, GJ
    SCHORN, TW
    SCHAFFER, LW
    BROTEN, TP
    SIEGL, PKS
    PATCHETT, AA
    GREENLEE, WJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (24) : 4068 - 4072
  • [40] Pharmacology of J-104,132, a potent, orally-active, mixed ETA/ETB endothelin receptor antagonist
    Nishikibe, M
    Ishikawa, K
    Fukuroda, T
    Ohta, H
    Kanoh, T
    Ozaki, S
    Noguchi, K
    Saito, M
    Uehara, S
    Williams, D
    Kivlighn, S
    Krause, S
    Gabel, R
    Zingaro, G
    Nolan, N
    O'Brien, J
    Clayton, F
    Lynch, J
    Pettibone, D
    Siegl, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R511 - R511